U.S. market Closed. Opens in 5 hours 20 minutes

PBYI | Puma Biotechnology, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for PBYI we got that it has weak fundamentals where Valuation is considered to be fairly valued, Profitability is very poor, Growth is very good and Health is frighteningly weak.

Valuation (55%)

Company Industry
P/E Ratio (TTM) 15.78 -22.97
PEG Ratio (TTM) -0.37 17.36
P/S Ratio (TTM) 0.64 49.62
P/B Ratio (TTM) 2.84 19.20
P/FCF Ratio (TTM) 4.20 1.43
Price to 5YR AVG Earnings Ratio -3.67 -2.06
Price to 5YR AVG FCF Ratio 46.23 -7.44

Profitability (35%)

Company Industry
ROA (TTM) 4.25% -4.06%
ROE (TTM) 18.20% 21.29%
Net Profit Margin (TTM) 3.98% -1,299.04%
ROIC 5YR AVG -7.18% 17.41%

Growth (77%)

4QTR AVG 3YR AVG 5YR AVG
EPS 37.02% 36.68% 473.55%
Revenue -0.08% 1.21% -0.59%
Net Income 37.75% 35.38% 495.34%
Cash Flow 34.31% 861.34% 535.73%

Health (26%)

Company Industry
Current Ratio (TTM) 1.32 6.01
Quick Ratio (TTM) 1.23 5.73
D/E Ratio (TTM) 1.94 -17.30
Interest Coverage (TTM) 1.41 1.23
Piotroski F-Score 5 5
Altman Z-Score N/A 13.35
LTL to 5YR AVG FCF 21.72 0.18
Shares Outstanding Growth 5YR AVG 4.48% 123.47%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙